pulmonologyadvisor17h
Study Compares Single-Inhaler Triple Therapies for Treatment of COPD
For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.
News Medical on MSN4d
Study finds no clinical advantage of budesonide inhaler over fluticasone in COPD
A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...
Medical Xpress8d
Study compares single-inhaler triple therapies for treatment of COPD
DOI: 10.1136/bmj-2024-080409 Meng-Ting Wang et al, Environmentally friendly inhaler regimens for COPD, BMJ (2024). DOI: 10.1136/bmj.q2825 ...
pulmonologyadvisor2d
COPD: Early Disease May Be Linked to Impaired FEV1/FVC Trajectories, Wheezing
Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...
2minutemedicine.com3d
Different single inhaler triple therapies appear to have similar clinical outcomes for chronic obstructive pulmonary disease
In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...
The 8 Best Air Purifiers, According To Testers And Pros
The best air purifiers can help filter fine particles, gases and other pollutants from the air you breathe. See our top picks ...
pharmaphorum4d
Smart sensor cleared for use with AZ asthma, COPD inhalers
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers ... disease (COPD). Sales of Breztri ...